Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Depreciation & Amortization (CF) came in at $7.6 million in Q4 2025, up 10.54% year-on-year from $6.9 million in Q4 2024, and down 0.93% quarter-over-quarter from $7.7 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $7.6 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 10.54% year-over-year to $7.6 million in Q4 2025; TTM through Dec 2025 was $30.2 million, a 1.92% decrease from a year earlier, with the FY2025 full-year figure at $30.2 million, down 1.64% from the prior year.
  • Depreciation & Amortization (CF) declined to $7.6 million in Q4 2025 per PBH's latest filing, from $7.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $8.5 million in Q1 2022 and bottomed at $6.9 million in Q4 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $7.8 million (2024), against an average of $7.8 million.
  • Across the five-year window, Depreciation & Amortization (CF) climbed 12.58% in 2022 and decreased 10.18% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $8.0 million in 2021, then gained by 0.99% to $8.1 million in 2022, then retreated by 5.95% to $7.6 million in 2023, then dropped by 10.18% to $6.9 million in 2024, then grew by 10.54% to $7.6 million in 2025.
  • Per Business Quant, the three latest PBH Depreciation & Amortization (CF) figures stand at $7.6 million (Q4 2025), $7.7 million (Q3 2025), and $7.7 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 7.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.59 Mn
Dec 31, 2025 7.59 Mn
Sep 30, 2025 7.66 Mn
Sep 30, 2025 7.66 Mn
Jun 30, 2025 7.67 Mn
Jun 30, 2025 7.67 Mn
Mar 31, 2025 7.25 Mn
Mar 31, 2025 7.25 Mn
Dec 31, 2024 6.87 Mn
Dec 31, 2024 6.87 Mn
Sep 30, 2024 7.93 Mn
Sep 30, 2024 7.93 Mn
Jun 30, 2024 8.12 Mn
Jun 30, 2024 8.12 Mn
Mar 31, 2024 7.84 Mn
Mar 31, 2024 7.84 Mn
Dec 31, 2023 7.65 Mn
Dec 31, 2023 7.65 Mn
Sep 30, 2023 7.64 Mn
Sep 30, 2023 7.64 Mn